sameAs
The Zika ChallengeAnalysis of the subcellular localization of hepatitis C virus E2 glycoprotein in live cells using EGFP fusion proteinsThe need for global R&D coordination for infectious diseases with epidemic potential.Best practices for sharing information through data platforms: establishing the principlesData sharing in public health emergencies: a call to researchersComparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.Protein-Protein Interactions between Hepatitis C Virus Nonstructural ProteinsSecondary Structure of the 3' Terminus of Hepatitis C Virus Minus-Strand RNADeveloping a vaccine against ZikaA review of vaccine research and development: human enteric infectionsPriority-setting for achieving universal health coverage2009 Pandemic influenza A virus subtype H1N1 vaccination in Africa--successes and challenges.Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets.A review of vaccine research and development: human acute respiratory infections.A review of vaccine research and development: the human immunodeficiency virus (HIV).Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008.Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.The 2009 A (H1N1) influenza virus pandemic: A review.WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.Global production capacity of seasonal influenza vaccine in 2011.Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.Strengthening health systems for universal health coverage and sustainable developmentBeyond Ebola: a new agenda for resilient health systems.On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa.Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy.Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.Human vaccine research and development: an overview.A review of vaccine research and development: meningococcal disease.A review of human vaccine research and development: malaria.The promise of conjugate vaccines for Africa.First generation leishmaniasis vaccines: a review of field efficacy trials.Reducing empiricism in malaria vaccine design.Cholera in disasters: do vaccines prompt new hopes?Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits.Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis.Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells.Hepatitis C virus IRES efficiency is unaffected by the genomic RNA 3'NTR even in the presence of viral structural or non-structural proteins.Systems science for universal health coverage.The third global patient safety challenge: tackling medication-related harm.
P50
Q24247045-D4A13F9F-5EDE-45FD-878F-BC89CFF4DF82Q24295546-4FE5CDBD-F685-4EAD-9015-B4798482BA23Q26250280-36CB13B4-1DCA-41E8-8820-965A10883097Q27469125-AE702908-3A73-4B33-9829-47FDDBF6230CQ27469138-CA4E7AAE-F866-4F5D-A7E0-154E3E4A7C70Q27472916-E04B5D74-D02C-452E-8A3F-1FDD594B77E9Q27473469-8ACBAB98-DF9E-4CB1-9EE0-CCD2280E35B6Q27473515-EBFAE391-541A-4853-82FC-64E0E6DD0239Q27826418-4D0C6A14-82CA-4BB1-B90C-7BBA8A25AAF2Q28297809-9BAA0946-6877-4BFF-BE57-5E788A562905Q30062017-D74998EB-C52D-4489-95D4-DD569C328A88Q30223838-81693E31-498D-4357-9DF2-6ECAC6E54678Q30224970-64B8942B-4865-4925-9590-DF5A64ABE73CQ30351377-61C86784-59A0-40D4-B085-95499CB70E08Q30353341-347E9306-8811-4FF7-9048-AA0C8A0E461EQ30369688-499C1E5B-5F82-454E-B6D7-DC3C3F288926Q30389462-A9EC0B45-E5B9-4387-823E-7187037E94C6Q30390380-2115071D-817E-4AA1-AEC6-3C39C5FB3AEBQ30403997-BECD442A-8C21-4401-9990-AF40849E9C5CQ30423559-B28094F6-A5DF-46B2-99B7-844CF5B98B17Q33514828-ADD18CDF-55D9-4110-B862-79C255F999E7Q33844860-62A463F8-8D27-4D9C-8F96-C7337255F122Q33909611-A81DF655-5641-40D1-B01B-5FB58B37B492Q33924959-DB5196FF-5DCF-4E58-A7BA-32308B458ED4Q34359766-CF49462D-8A36-4E5D-8F27-37DBE1DCDADDQ34488529-2EEF5E60-CEFB-43F6-943C-9B4A4C716001Q34507237-B756FAB8-0DBC-4C99-B1C3-32691C039370Q36267071-91D3F968-046B-4630-A624-632B7CC61601Q36452114-5F667FBF-8CCB-479A-A275-4AC77CA80FD9Q36625367-90E699ED-A01E-4C07-911A-78033C0A0D36Q36840253-A8855E45-241E-4A5C-95AE-812F2A343843Q37308029-6CBF073D-70E7-4920-9164-5F2C94B6BCCEQ37698761-89BC3C2E-01AA-48DD-9A47-55D6D8B04FA2Q38936929-D92D79CB-C5E2-4351-BCB0-E64E18FBEC87Q40024416-534ABFA4-A00D-458C-B73A-6E72EC0AC47CQ40246185-57EAD2B2-FB4D-4BCB-A272-EF75BBDCF34BQ40472043-640FBC69-9983-42FD-9F88-92498D458636Q40644343-C38C077F-B0C2-4F6E-8AB5-FE7DAAE4CF83Q42333998-204C1F5E-B0B9-43AC-9062-985B033B4E5BQ42340555-C55855E9-B676-41DD-8474-C7958CD89EC8
P50
description
Frans microbiologe
@nl
French virologist and science writer
@en
französische Wissenschaftlerin
@de
französische Wissenschaftlerin
@de-at
französische Wissenschaftlerin
@de-ch
investigadora
@ca
microbióloga francesa
@ast
virologue française, directrice de nombreux organismes de santé publique
@fr
name
Marie Paule Kieny
@de
Marie Paule Kieny
@en
Marie Paule Kieny
@es
Marie Paule Kieny
@nl
Marie Paule Kieny
@sl
Marie-Paule Kieny
@aa
Marie-Paule Kieny
@af
Marie-Paule Kieny
@ak
Marie-Paule Kieny
@aln
Marie-Paule Kieny
@an
type
label
Marie Paule Kieny
@de
Marie Paule Kieny
@en
Marie Paule Kieny
@es
Marie Paule Kieny
@nl
Marie Paule Kieny
@sl
Marie-Paule Kieny
@aa
Marie-Paule Kieny
@af
Marie-Paule Kieny
@ak
Marie-Paule Kieny
@aln
Marie-Paule Kieny
@an
altLabel
Marie-Paule Kieny
@de
Marie-Paule Kieny
@en
Marie-Paule Kieny
@es
Marie-Paule Kieny
@fr
Marie-Paule Kieny
@nl
Marie-Paule Kieny
@sl
prefLabel
Marie Paule Kieny
@de
Marie Paule Kieny
@en
Marie Paule Kieny
@es
Marie Paule Kieny
@nl
Marie Paule Kieny
@sl
Marie-Paule Kieny
@aa
Marie-Paule Kieny
@af
Marie-Paule Kieny
@ak
Marie-Paule Kieny
@aln
Marie-Paule Kieny
@an
P106
P269
P21
P214
189150468403604172796
P269
P27
P31
P691
P734
P735
P7859
viaf-189150468403604172796